"Our central vision in the Cancer Center is translating the research of basic scientists into the solution of clinical problems," says Lowell Schnipper, MD, chief of the Division of Hematology/Oncology at Beth Israel Deaconess Medical Center, as well as deputy associate director for Clinical Sciences and member of the Executive Committee at DF/HCC

The National Academy of Sciences announced on October 9 that Nancy Andrews, MD, PhD (CHB), Graham Colditz, MD, DrPH (BWH/HSPH), Stephen Elledge, PhD (BWH), and Robert Martuza, MD (MGH), were among 65 new members elected to the Institute of Medicine

On October 4, the Center Scientific Council (CSC) hosted a symposium titled “Targeting the PI3K Pathway for Cancer Therapy,” the first of a quarterly series of workshops on emerging avenues of interdisciplinary research

Capping a rigorous nine weeks of research, 21 students recently presented their findings to an audience of scientists and lab mates, family and friends

In September, Rosalind Segal, MD, PhD (DFCI), professor of neurobiology, received the 2006 NIH Director’s Pioneer Award, a five-year, $2.5 million grant given to an outstanding scientist who pioneers new approaches to biomedical research

For more than two decades, DF/HCC laboratory researchers have been homing in on a signaling network that genes and cells use to talk to each other — the phosphoinositide 3-kinase (PI3K) pathway